"EXPERIENCE at a GLANCE"

W David Watkins

• Formal training
  • BS/MS Pharmacy (Univ of Texas, Austin)
  • PhD Toxicology (Univ of Michigan)
  • MD (Univ of Colorado, Denver)
  • Internship/Residency/Chief Resident/Fellowship (Anesthesiology/Critical Care Medicine) (Harvard Univ, Mass. General Hosp)
  • Mini-MBA (Biological Scientists) (Univ of Pittsburgh)
• Academic/Clinical experience
  • Appointments
    • Assistant professor pharmacology: Univ Colorado School of Medicine; laboratory director, PhD/MS thesis research advisor/mentor
    • Professor of pharmacology: Duke Univ, PhD thesis research advisor/mentor, Member, multiple graduate thesis committees
    • Assistant, Associate professor of Anesthesiology/CCM: Harvard Med School, Mass. General Hospital
    • Chairman and Professor (tenure) of Anesthesiology/CCM: Duke Univ, ACGME Approved Residency program
    • Professor (tenure), and vice-chairman (Clinical Affairs) of Anesthesiology/CCM: Univ of Pittsburgh; Chief of Anesthesiology, Montefiore Hospital; University of Pittsburgh Medical Center
• Activities
  • NIH
    • Sponsored investigator: PI, co-PI, co-director, SCORE (ARDS)
    • SAT Study Section member
  • FDA
    • First Visiting Scholar of the FDA (CDER), medical officer--sabbatical
    • Consultant to FDA Advisory Panel on Analgesia and Anesthesia
  • Publications
    • Over 200 peer reviewed scientific papers, chapters, books
    • Multiple abstracts for presentations
    • Publication/manuscript reviewer:
    • Anesthesiology
    • International Journal for Quality in Health Care
  • Memberships/Presentations
    • Multiple professional and clinical research societies
    • AAMC—Invited speaker for first academic/industry symposium on improving the process of industry sponsored clinical research/trials (Roger Meyer (AAMC), chair)
  • International institutional advisory/consultant positions
    • Advisor/consultant: University of Vienna (3 years)
    • Advisor/consultant: Tri-Defense Service Medical Center (Taipei, Taiwan) 2 years, new commercial clinical research organization (Taipei)
    • Advisor/consultant:  Juntendo University (Tokyo, Japan) 2 years; Japanese Pharma; Japanese CRO
    • Consultant in China for US venture capital group and the Univ of Pittsburgh to create US/China partnership to develop Traditional Chinese Medicine (TCM)
    • Consultant: Pharma Bio-Research/Univ of Groningen clinical trials partnership initiative, The Netherlands
    • Consultant/Advisor: Taiwan Total Management Consulting Ltd.
    • Consultant/Advisor: Delex Pharmaceuticals, Toronto, Canada
    • Consultant/Advisor: Xenome, Pty, Brisbane, Australia
• Pharma/Biotech experience
  • Academic Health System/industry interface
    • Established dedicated phase I-III clinical trials laboratory and clinical care facility, all supported by Industry sponsored clinical research projects—Dept of Anesthesiology, Duke Medical Center
    • Established Clinical Trials Program (industry-sponsored research) for the Department of Anesthesiology/CCM, University of Pittsburgh Medical Center—central office, infrastructural support, management, oversight for 150 faculty (including a multi-disciplinary Critical Care Medicine Division) dispersed among a multi-hospital/site network
    • Pittsburgh Clinical Research Network (PCRN)—Medical Director, Chief Medical Officer
    • Wholly-owned subsidiary of the Univ. of Pittsburgh Medical Center created to provide managed access to the research/clinical capabilities for industry sponsors
    • Harvard Clinical Research Institute—Chief Operating Officer
    • Initiative of the Dean, Harvard Medical School to create a partnership supported by Partners in Health and the Care Group (health systems comprised of the Harvard teaching affiliated hospitals)
    • Consultant for Clinical Research Institute initiative of the University of Cincinnati Medical Center
  • Industry sponsor consultant/advisor
    • Abbott
    • Burroughs Wellcome
    • Ciba-Geigy
    • Glaxo
    • Hoechst-Roussel
    • J and J (Jannsen, Ethicon)
    • Lilly
    • Monsanto
    • Novartis
    • Pharmacia
    • Purdue Pharma
    • Searle
    • Tissue Informatics, Inc (Scientific Advisory Board)
    • Upjohn 
    • DIRAmed (Advisory Board, Clinical Research Advisor)
    • Parexel (Medical Director)—multiple clients, including:
    • Sepracor
    • Delex (Biotech)
    • SkyePharma
    • King Pharmaceuticals
    • Preferred Services collaboration with CenterWatch (Drug industry trade publication)
    • Ernst and Young (Compliance Leverage initiative advisory group)
    • Price Waterhouse Coopers (Clinical Research initiatives—HealthCare Division)
    • Cantox (Commercial preclinical toxicology and consulting company)
    • QrxPharma (US/Australia)--Consultant
    • Xenome Ltd (Brisbane, Australia)—Consultant and Chairman, Scientific Advisory Panel (2004)
    • Delex (Toronto, CA)—Consultant and Member, Scientific Advisory Board (2004)
  • Health system-industry sponsor-CRO interface advisor/consultant
    • Australia
    • Austria
    • Canada
    • China
    • Ireland
    • Japan
    • Netherlands
    • Taiwan
    • United States
  • Industry organizations
    • Member, Pittsburgh Technology Council
    • Drug Information Association (DIA)
    • Chairman, CME committee
    • Member, SIAC—Clinical Research
    • Member, SIAC—Core Committee
    • Panel Chair, speaker, moderator, annual meetings, regional meetings
    • Member, DIA Clinical Investigator Certification Program Advisory Board
    • Member, DIA Clinical Investigator Advisory Board
    • Formal Nominee, DIA Board of Directors (2004

Copyright: 2005